Evan W. Piette, MD, Dermatologist

Being diagnosed with an illness can be stressful for patients and family members alike. My goal is to provide high quality, individualized care through a patient centered approach. I have particular interests in minimally invasive and robotic cancer surgery, reconstruction of the upper urinary tract and treatment of renal stones.

I pursue providing the highest quality care in a friendly, professional clinic. My experiences in global health, US military service, and in clinical care have taught me the value of providing patients with evidence-based management options that best fit patients’ overall needs. This includes striving for clear, detailed, patient friendly information about a patient’s disease and the risks and benefits of treatment options so the patient and I can come to the best management plan at each stage of their disease. I practice General Dermatology, including skin cancer, acne, allergic contact dermatitis, hidradenitis suppurativa, psoriasis and eczema, as well as treatment of skin cancer and removal of “lumps and bumps”. In addition, I coordinate clinical trials for our section, working with our providers to bring cutting-edge treatments to our community for such diseases as psoriasis and atopic dermatitis. My areas of non-pharmacological research interest include infectious diseases and epidemiology of skin diseases. I am an active member of the American Academy of Dermatology and, most recently, the American Contact Dermatitis Society.

I focus my dermatology practice on skin cancer. In particular, I see patients with rare lymphomas of the skin (cutaneous T cell lymphoma or cutaneous B cell lymphoma) and patients who are at high risk of developing skin cancer due to either a suppressed immune system (organ transplant recipients or patients with chronic lymphocytic leukemia) or other genetic factors. I collaborate with other specialists to provide coordinated multidisciplinary care, while I work with my patients to create a skin cancer management and prevention plan that best fits their needs.I am a member of the United States Cutaneous Lymphoma Consortium and the International immunosuppression and Transplant Skin Cancer Collaborative which allows me to actively collaborate with physicians who have similar interests. I am grateful to be able to develop relationships with and learn from my patients over time, teach residents and medical students about rare skin disorders, and participate in research to help advance our knowledge within the field of cutaneous oncology.